Targeted Advances in ALK+ NSCLC | Supplements And Featured Publications

Expert Perspectives in the Evolving ALK+ NSCLC Paradigm

March 24, 2020

In a wide-ranging discussion, Alexander Drilon, MD; Julia Rotow, MD; Thomas E. Stinchcombe, MD; and Ashish Saxena, MD, PhD, provide expert insight on developments in ALK-positive non–small cell lung cancer.

x